Lista de obras - María Jara-acevedo - Dominio Público Uruguay

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

artículo científico publicado en 2011

Analysis of gene variants in the GASH/Sal model of epilepsy

scientific article published on 13 March 2020

Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas

artículo científico publicado en 2013

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

artículo científico publicado en 2013

CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults.

artículo científico publicado en 2011

Cell-cycle distribution of different cell compartments in normal versus reactive bone marrow: a frame of reference for the study of dysplastic hematopoiesis

artículo científico publicado en 2011

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

artículo científico publicado en 2010

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

artículo científico publicado en 2015

Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis

article by Iván Alvarez-Twose et al published 20 April 2012 in Journal of Clinical Oncology

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

artículo científico publicado en 2015

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

artículo científico publicado en 2011

Flow cytometry criteria for systemic mastocytosis: bone marrow mast cell counts do not always count

artículo científico publicado en 2013

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool

artículo científico

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

artículo científico publicado en 2019

Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis

artículo científico publicado en 2013

Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

artículo científico publicado en 2014

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

artículo científico publicado en 2012

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

artículo científico publicado en 2015

Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach

artículo científico publicado en 2009

Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis ⬇️

artículo científico publicado el 1 de abril de 2011

KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients

article

Mast cell-related disorders presenting with Kounis syndrome

artículo científico publicado en 2012

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.

artículo científico publicado en 2010

Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.

artículo científico publicado en 2013

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

artículo científico publicado en 2013

Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality

artículo científico publicado en 2015

Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

artículo científico publicado en 2009

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

artículo científico publicado en 2013

Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis.

artículo científico publicado en 2013

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

artículo científico publicado en 2014

Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms

artículo científico publicado en 2011

Lista de obras de María Jara-acevedo

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

Analysis of gene variants in the GASH/Sal model of epilepsy

Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults.

Cell-cycle distribution of different cell compartments in normal versus reactive bone marrow: a frame of reference for the study of dysplastic hematopoiesis

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

Flow cytometry criteria for systemic mastocytosis: bone marrow mast cell counts do not always count

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis

Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach

Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis ⬇️

KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients

Mast cell-related disorders presenting with Kounis syndrome

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.

Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality

Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis.

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms